Biography

Anna transitioned to Celularity Inc., from Johnson & Johnson Inc., where her tenure included 25 years of working across three sectors: Medical Devices, Pharmaceuticals, and Consumer Healthcare Industry. She held positions with increasing responsibilities, advancing from Manager of R&D to Director of R&D to Senior Director of R&D/Head of Emerging Science and Innovation. As part of her tenure, Anna led cross-enterprise efforts, focused on emerging technology development, the discovery of novel cell-based technologies, biomaterials, and nanotechnologies, and the development of innovative products to enhance the healing and regeneration of human tissues and organs.

---

Research Interest

Orthopedics